Cannabis reclassification is 'a real milestone' for the industry," says Curaleaf's Boris Jordan thumbnail

Cannabis reclassification is ‘a real milestone’ for the industry,” says Curaleaf’s Boris Jordan

Boris Jordan, co-founder and executive chairman of Curaleaf, joins ‘Squawk on the Street’ to discuss the significance of cannabis’ reclassification, the federal tax code around cannabis, and much more.

Inside one of the biggest cannabis investor conferences thumbnail

Inside one of the biggest cannabis investor conferences

The cannabis buzz. Is regulation a catalyst for pot stocks? Is it time to buy? With FM trader Tim Seymour, CNBC’s Melissa Lee and the Fast Money traders, Dan Nathan,…

Green Growth Brands CEO: Breaking into Cannabis Retail | Mad Money | CNBC thumbnail

Green Growth Brands CEO: Breaking into Cannabis Retail | Mad Money | CNBC

He’s spent time in the C-Suite at Victoria’s Secret and DSW, and now, he’s turning his attention to cannabis. Jim Cramer finds out what retailers can bring to the table…

Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC thumbnail

Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC

The whole cannabis cohort has been smoking hot, but not all pot stocks are created equal. Jim Cramer checks in with the CEO of growth-focused Green Thumb Industries to try…

Firing up the cannabis trade thumbnail

Firing up the cannabis trade

Trader Tim Seymour on why he’s long a number of cannabis stocks. With CNBC’s Courtney Reagan and the Fast Money traders, Victoria Fernandez and Delano Saporu. For access to live…

Aurora Cannabis chair talks Peltz appointment and the future of the cannabis industry thumbnail

Aurora Cannabis chair talks Peltz appointment and the future of the cannabis industry

Canadian cannabis company Aurora announced that it has appointed hedge fund billionaire Nelson Peltz as a strategic advisor. Aurora Cannabis Executive Chairman Michael Singer joins “Squawk Box” to discuss the…

GW Pharma CEO on new cannabis-derived drug thumbnail

GW Pharma CEO on new cannabis-derived drug

GW Pharmaceuticals CEO Justin Gover discusses how the company secured FDA approval for its cannabis-derived drug and what it says about the future of cannabis-derived drugs.

Aurora Cannabis CEO discusses outlook of cannabis industry thumbnail

Aurora Cannabis CEO discusses outlook of cannabis industry

Virginia is the latest state to approve adult-use marijuana legalization following New Jersey. Aurora Cannabis CEO Miguel Martin says he sees booming opportunity in the cannabis industry as more states…

Cronos CEO on nicotine vaping versus cannabis vaping thumbnail

Cronos CEO on nicotine vaping versus cannabis vaping

Cronos CEO Mike Gorenstein tells Jim Cramer what his company is doing different to enter the cannabis vaping space, particularly in the Canadian market.

Here's what's driving the cannabis sector going forward thumbnail

Here’s what’s driving the cannabis sector going forward

Canopy Growth co-CEO Bruce Linton was ousted from the company on Wednesday, which led the stock to dip on the news but rally within a few hours. Sam Masucci, CEO…